Skip to main navigation Skip to search Skip to main content

Whole-genome sequencing of patients with rare diseases in a national health system

  • Cambridge University Hospitals NHS Foundation Trust
  • University of Cambridge
  • NHS Blood and Transplant
  • KU Leuven
  • Jeffrey Cheah Biomedical Centre
  • Imperial College London
  • Medical Schoo
  • University of Oxford
  • Oxford University Hospitals Trust
  • Genomics England Ltd.
  • Barts and The London Queen Mary's School of Medicine and Dentistry
  • MRC Mitochondrial Biology Unit
  • King's College London
  • UCL University College London
  • UK Renal Registry
  • Department of Paediatric Nephrology
  • GSTT Guy's and St Thomas' NHS Foundation Trust
  • NIHR Cambridge Biomedical Research Centre
  • CRUK Cancer Research UK
  • European Molecular Biology Laboratory Cambridge
  • University of Bristol
  • University Hospital Bristol NHS Foundation Trust
  • NIHR Oxford Biomedical Research Centre (BRC)
  • Clinical Genetics Department

Research output: Contribution to journalArticlepeer-review

463 Citations (Scopus)
2525 Downloads (Pure)

Abstract

Most patients with rare diseases do not receive a molecular diagnosis and the aetiological variants and causative genes for more than half such disorders remain to be discovered1. Here we used whole-genome sequencing (WGS) in a national health system to streamline diagnosis and to discover unknown aetiological variants in the coding and non-coding regions of the genome. We generated WGS data for 13,037 participants, of whom 9,802 had a rare disease, and provided a genetic diagnosis to 1,138 of the 7,065 extensively phenotyped participants. We identified 95 Mendelian associations between genes and rare diseases, of which 11 have been discovered since 2015 and at least 79 are confirmed to be aetiological. By generating WGS data of UK Biobank participants2, we found that rare alleles can explain the presence of some individuals in the tails of a quantitative trait for red blood cells. Finally, we identified four novel non-coding variants that cause disease through the disruption of transcription of ARPC1B, GATA1, LRBA and MPL. Our study demonstrates a synergy by using WGS for diagnosis and aetiological discovery in routine healthcare.

Original languageEnglish
Pages (from-to)96-102
Number of pages7
JournalNature
Volume583
Issue number7814
Early online date24 Jun 2020
DOIs
Publication statusPublished - 2 Jul 2020

Fingerprint

Dive into the research topics of 'Whole-genome sequencing of patients with rare diseases in a national health system'. Together they form a unique fingerprint.

Cite this